More than 1,000 people show up for Livingston Co. Relay for Life Aug 9, 2008
One survivor, Val Boucher of Roanoke, who fought hairy cell leukemia several years ago, challenged those in attendance to fight back through treatment, fundraising and support. It is time for you yourselves to take action and make a difference, he said. (The Pantagraph newspaper)
Canada should follow the U.S. example on 'orphan' diseases Jul 18, 2008
While there are scores of drugs for those with cardiovascular ailments, a bevy of antidepressants and antibiotics, and more anti-impotence treatments than the world will ever need, there is a paucity of medications for pulmonary hypertension (the rare disorder that claimed the life of Mr. Bell's grandson), cervical dystonia, hairy cell leukemia and so on. There is little incentive for drug companies to do research on possible treatments for conditions that affect dozens or hundreds of people. (Globe and Mail)
Hodgkin Lymphoma Risk: Why Disease Affects Some, And Not Others; New Hypothesis From Twins Study Apr 6, 2008
4, 2008) A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). "We found that lower levels of the protein interleukin-12, involved in fighting intracellular infections, increases susceptibility to young adult Hodgkin lymphoma," says Wendy Cozen, D.O., M.P.H, associate professor of preventive medicine at the Keck School of Medicine of USC. " Cozen is lead... (Science Daily)
PLACES OF WORSHIP: Redeemer Lutheran Church Feb 9, 2008
Eisberg has had to deal with hairy cell leukemia, which has been eradicated, and prostate cancer, which doctors continue to monitor with regular checkups. The basicsLocation: 1084 W. Bullard Ave.Contacts: (559) 439-8500; online, redeemerfresno. (Fresno Bee -- Lifestyle)
Bedford Laboratories(TM) to Begin Shipping Pentostatin for Injection Aug 14, 2007
This product is AP rated and is equivalent to Nipent(R) by Hospira Inc. Pentostatin is indicated for the treatment of hairy cell leukemia. (Logo: ) "In our continuing effort to offer the most comprehensive and cost effective line of oncology and oncology adjunct products in the multisource industry, Bedford Laboratories is once again very pleased to offer this very important product," said David Gaugh, Vice President of Bedford Laboratories. (PR Newswire)
Hit with chemo full force Jul 19, 2007
Vonnie was diagnosed with Hairy Cell Leukemia and in Relay for Life terminology is now characterized as a three year survivor. Thinking back to the day when she received her diagnosis, Vonnie recalls telling her husband, Norman, while sitting in the clinic waiting room, I dont know why were here. (Mt. Lake Observer/Advocate, MN)
Study Analyzes Heart Attack Mortality Risk Associated With Hodgkin Disease Treatments Feb 9, 2007
(February 8, 2007) -- Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and. . (Science Daily)
Study Examines Second Cancer Risk Among Hairy Cell Leukemia Survivors Feb 9, 2007
Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and lymphoma, according to a new study ... Hairy cell leukemia is a malignancy of a type of white blood cell called B lymphocytes ... D., and colleagues at the National Cancer Institute examined the records for 3,104 patients with hairy cell leukemia who survived for at least two months after diagnosis. (Science Daily)
BYU Chemists Fight Cancer Nov 14, 2006
The drug, which has proven effective at fighting hairy cell leukemia and other forms of cancer, is very difficult and expensive to produce ... The compound has become the drug of choice for doctors who have patients with hairy cell leukemia ... Around 800 people are diagnosed with hairy cell leukemia each year. (The Daily Universe, UT)
An intrepid researcher Sep 5, 2006
Accomplishments: Discovered the drug Leustatin, now the standard treatment for hairy cell leukemia ... The drug, Leustatin, was approved in 1993 and is now the standard of care for hairy cell leukemia, inducing long-term, complete remissions in about 80 percent of patients. (San Diego Union-Tribune -- Business)
Mayne Acquires SuperGen's North American Oncology Products Jun 22, 2006
Nipent(R) is a treatment approved for patients with hairy cell leukemia and SurfaceSafe(TM) is a two step, towelette system to decontaminate surfaces where chemotherapy is mixed or administered. Commenting on the acquisition today, Mayne Pharma's Chief Executive Officer and Managing Director Dr. Thierry Soursac said, "A key element of Mayne Pharma's new strategy, presented last month, is to acquire niche marketed or close-to-market proprietary products that strengthen our oncology focus and... (PR Newswire)
SuperGen takes over distribution of leukemia drug Jun 7, 2006
Lipent currently is approved for treatment of hairy cell leukemia patients in the United States and in some European countries. Related Industry stories. (East Bay Business Times, CA)
High Benzene Levels Found In Some Soft Drinks May 21, 2006
-- ALL (acute lymphocytic leukemia) -- AML (acute myelogenous leukaemia) -- CLL (chronic lymphocytic leukemia) -- CML chronic myelogenous leukemia) -- HCL (hairy cell leukemia) -- Hodgkin's disease -- MDS (myelodysplastic syndrome) -- Multiple myeloma -- NHL (non-Hodgkin's lymphoma). Bear in mind that the benzene health threat associated with the jobs mentioned here are much higher than in the five sodas. (Medical News Today)
Patent offending Apr 20, 2006
Eventually, he found himself at the UCLA Medical Center, where he was diagnosed with a rare, progressive form of blood cancer called hairy cell leukemia. ANITA L. ARAMBULA and K.C. ALFRED / Union-Tribune. (San Diego Union-Tribune)
BioCryst Reports Fourth Quarter and Year-End 2005 Financial... Feb 8, 2006
This year is expected to be equally exciting and we are eager to continue to move our corporate and clinical programs forward," said Dr. Bugg. Conference Call The Company will sponsor a conference call at 10:00 am Eastern Time on Wednesday, February 8, 2006 to discuss the financial results and the status of each of our programs in more detail. This call is open to the public and can be accessed live either over the Internet from www.biocryst.com or by dialing 1-877-502-9274 (U.S.) or... (CNBC -- Research Alerts)
